Latest News

Huntington disease prevention trial shows creatine safe, slows progression

The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most participants. In addition, neuroimaging showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Medicinal marijuana: Patients battle stigma and misunderstanding

  • CPR: It's not always a lifesaver, but it plays one on TV

  • Goth teens could be more vulnerable to depression and self-harm

  • Brain scans predict response to antipsychotic medications

  • Older adults possess important forms of expertise

  • Covert and overt forms of sexism are equally damaging to working women

  • Retinoids may increase effectiveness of targeted therapies against high-risk leukemia

  • Air pollution linked to children's low academic achievement

  • Turning breath into words: New device unveiled to give paralysis victims a voice

  • Neurobiology: Light-activated learning

  •